Identifying compounds that prevent the binding of the SARS-CoV-2 S-protein to ACE2

We investigated compounds selected by molecular docking to identify a specific treatment for COVID-19 that decreases the interaction between angiotensin-converting enzyme 2 (ACE2) and the receptor-binding domain (RBD) of SARS-CoV-2. Five compounds that interact with ACE2 amino acids Gln24, Asp30, Hi...

Descripción completa

Detalles Bibliográficos
Autores principales: Benítez-Cardoza, Claudia Guadalupe, Vique-Sánchez, José Luis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8325380/
https://www.ncbi.nlm.nih.gov/pubmed/34358993
http://dx.doi.org/10.1016/j.compbiomed.2021.104719

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8325380/
https://www.ncbi.nlm.nih.gov/pubmed/34358993
http://dx.doi.org/10.1016/j.compbiomed.2021.104719

Ejemplares similares